We are not able to resolve this OAI Identifier to the repository landing page. If you are the repository manager for this record, please head to the Dashboard and adjust the settings.
<p>(A) At the <i>C. elegans</i> NMJ, the functional balance between GABA<sub>R</sub> and AChR signaling regulates post-synaptic muscle function. (B) L-AChR activation with the agonist levamisole (in water) suppressed Q35 aggregation at 5 µM, but enhanced aggregation at 50 µM. Mutant AChR <i>unc-38(e264)</i> is a control for AChR-mediated effect. (C) Reduction in GABA<sub>R</sub> function with lindane (in 10% EtOH) suppressed Q35 aggregation at 25 µM, and enhanced aggregation at 1 mM concentration (relative to EtOH control treatment). (D) Effect on Q35 aggregation by decrease in GABA with <i>unc-49</i> or <i>unc-47</i> RNAi, and by inhibition of GABA in <i>unc-47(gk192)</i> or <i>unc-30(e191)</i> mutant backgrounds. (E) Incubation with 50–200 mM GABA (in water) suppressed Q35 aggregation. GABA at 50 mM abolished the suppressor effect of <i>gei-11</i>, by “re-balancing” the GABAergic-cholinergic signaling. (F) Real-time qPCR analysis of <i>hsp-70</i> (<i>C12C8.1, F44E5.4</i>) levels in 5 day old wt animals upon treatment with ACh, levamisole or the GABA<sub>R</sub> antagonist Lindane, or upon decrease in GABAergic signaling by either RNAi or mutant backgrounds of <i>unc-47(gk192)</i>, <i>unc-49(e407)</i> or <i>unc-30(e191)</i>. Student t-test **<i>p</i><0.01 and ***<i>p</i><0.001; data and statistics are relative to Q35;vector control (±SD) (RNAi controls: <a href="http://www.plosgenetics.org/article/info:doi/10.1371/journal.pgen.1003711#pgen.1003711.s008" target="_blank">Table S1</a>).</p
Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.